Clinical trial

Exploring the Efficacy of Pure Honey Dressing in Contrast to Alvogyl in the Resolution of Dry Socket: A Comparative Analysis

Name
639/NID/24
Description
Dry socket, or Alveolar Osteitis, is the most common complication that can follow a tooth extraction. Over the years, various approaches have been employed to expedite the healing process and alleviate the associated symptoms. Among these, Alvogyl has been the most commonly used dry socket dressing all over the globe. However due to Alvogyl's potential side effect of causing a foreign body reaction \& ultimately necrosis of the alveolar bone if left in the socket along with its high cost, scientists have sought to develop new techniques. Among them, Honey dressing has heralded promising properties in facilitating the resolution of dry socket, thus opening the window of a side-effect free natural viable alternative to Alvogyl. In this research, we aim to compare the efficacy of pure Honey as a dry socket dressing in comparison to Alvogyl.
Trial arms
Trial start
2024-06-01
Estimated PCD
2024-12-01
Trial end
2025-01-01
Status
Not yet recruiting
Phase
Early phase I
Treatment
Alvogyl
Alvogyl soaked in a sterile gauze will be applied to cover the socket.
Arms:
Control (Alvogyl) Group
Honey
Honey soaked in a sterile gauze will be applied to cover the socket.
Arms:
Study (Honey) Group
Size
40
Primary endpoint
Pain relief
Patients will be reviewed at 5 min post-medication, 30 min post-medication, 60 min post-medication, 2nd day post-medication, 4th day post-medication and 7th day post-medication.
Eligibility criteria
Inclusion Criteria: 1. Patients over 18 years of age of both genders. 2. Patients who underwent extraction of teeth and were clinically diagnosed with dry socket at the OMFS department of NID, Multan. 3. Patients which give informed consent. Exclusion Criteria: 1. Patients below the age of 18 and above the age of 70. 2. Patients with various bone diseases, including osteoporosis \& a history of taking oral or intravenous bisphosphonates 3. Patients with a history of radiotherapy on the head, neck, and jawbones were excluded from this study, 4. Patients with systemic diseases such as diabetes mellitus, hepatic dysfunctions, blood dyscrasias, and bleeding disorders 5. Patients with allergy to Ibuprofen \& honey 6. Patients having symptoms similar to dry socket due to retained root pieces, oroantral communication, or any bony or soft tissue pathology by the help of a radiograph 7. Patients who did not give informed consent.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'interventionModelDescription': 'Patients will be divided into the following two groups:\n\n1. Study group\n2. Control group\n\nIn the study group, after flushing the socket with normal saline, 2 ml of Honey soaked in a sterile gauze will be applied to cover the socket, whereas in the control group, a gauze with Alveogyl will be used to cover the socket instead of Honey.', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'maskingDescription': 'Participants will be blinded about the use of honey or Alveogyl in the dressing.', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 40, 'type': 'ESTIMATED'}}
Updated at
2024-06-13

1 organization

2 products

1 indication

Product
Alvogyl
Product
Honey